{"ticker": {"uuid": "f3cae6a6-aa07-477b-a27c-1309caaf6272", "symbol": "OBIO", "name": "Orchestra BioMed Holdings Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to earnings forward of Orchestra BioMed Holdings, Inc. \u2013 BOATS:OBIO", "summary": "This article provides financial information for Orchestra BioMed Holdings, Inc. (OBIO), specifically focusing on its \"Price to earnings forward\" metric. The content indicates that the market was closed with no trades recorded at the time of the data.", "url": "https://www.tradingview.com/symbols/BOATS-OBIO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T19:41:06", "published_display": "11 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OBIO - Orchestra BioMed Holdings Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings and comprehensive financial data for Orchestra BioMed Holdings Inc. (OBIO). It details the company's stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations, offering a snapshot of its", "url": "https://finviz.com/stock?t=OBIO&b=2&p=w&ty=lf&page=3", "source_name": "Finviz", "published_at": "2026-07-06T06:11:57", "published_display": "06 Jul 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Share Price, OBIO Stock News, OBIO Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE4tdU8wTmo0ODBneTJHRnFSbUc5ZC05SEx3Szl6Q0ZBdHBoNFl4NjZuMkZsZFZpU2lqcC12VEVnRG5TTUVKdldYNldsMllZTmtwNnZDSDNn?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T05:50:02+00:00", "published_display": "03 Jul 2026 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Darren Sherman Sells 15,000 Shares of Orchestra Bi", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPa0c0d2JWX0NrcjZZRWl2SFAtNDZvNXl5SXUwSXhvZ3NyMFExT1FKUTkzY2ZpYTlxdXhyU2hPLVJ2UnlMN2Y3V0NDRkRVd3puZ2EzMVE2UjNEN2lTQWVHRVpYaTBRVW90c3g4WnMzRWdsa1BpNXctQmEyV1prSFgwQ1NqcmM5TWtiT1g3RGxfX3J0ZzlqbWpDXzdMNVpuZjU4REJMaE1zSDRqY2VmN1BXNFJRZUp3ZDR4MGQ3alhIUjU?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-02T22:44:36+00:00", "published_display": "02 Jul 2026 22:44", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan", "summary": "Darren Sherman, a director and officer of Orchestra BioMed Holdings (OBIO), sold 15,000 shares of common stock at a weighted average price of $4.27 per share. This transaction, executed under a pre-established Rule 10b5-1 trading plan adopted on December 18, 2025, involved sales ", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-5b4299d483a1.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:01", "published_display": "02 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO)", "summary": "Darren Sherman has filed a Form 144 indicating an intent to sell 15,000 shares of Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) common stock, with a proposed sale date of June 1, 2026, and a reported gross amount of $58,049.53. The filing also details prior restricted stock vest", "url": "https://www.stocktitan.net/sec-filings/OBIO/144-orchestra-bio-med-holdings-inc-sec-filing-c8a8815dc3ce.html", "source_name": "Stock Titan", "published_at": "2026-07-01T15:45:05", "published_display": "01 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings' Market Cap Up US$40m Following Year Of Insider Stock Buying", "summary": "Orchestra BioMed Holdings (NASDAQ:OBIO) saw its market capitalization increase by US$40 million after a 16% stock rise, rewarding insiders who bought shares over the past year with a 36% gain. Insiders purchased US$321.7k worth of stock, now valued at US$438.9k, with the biggest ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-obio/orchestra-biomed-holdings/news/orchestra-biomed-holdings-market-cap-up-us40m-following-year", "source_name": "Simply Wall Street", "published_at": "2026-06-30T11:39:50", "published_display": "30 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes", "summary": "Orchestra BioMed Holdings, Inc. has been added to the Russell 3000 and Russell 2000 Indexes, effective July 1, 2026, as part of the annual reconstitution. This inclusion is expected to increase the company's visibility within the investment community. The Russell indexes are wide", "url": "https://www.moomoo.com/news/post/72190309/orchestra-biomed-joins-russell-3000-and-russell-2000-indexes", "source_name": "Moomoo", "published_at": "2026-06-30T05:09:33", "published_display": "30 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2500 Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPNWZyTGhoYWtwc3FleG83SGRyVmpiT0ZZOFlrOXYzX3NIajE2RFY0NzNSR01mZS1aT3pBMVZNakk3aE5pX2hicFhMNTVpaDZVNlZNQ3IwaUJYMHhIUWRfMWROMWdjTTRSNXFVSWsxaXdla3FKa2N6aUdCdlJFajA5RGZhQ3lZM3ZSaENQY2NpRElhSV8zMFZ6dDlhRlo5VUZwQjlYOTIyZE1OQnp4bmNOOWF6V2ZoYWxZRUhFUDFENTVZYUFSbklIdF8yTUkxQzYt?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-29T19:59:08+00:00", "published_display": "29 Jun 2026 19:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Index", "summary": "Orchestra BioMed Holdings, Inc. (NasdaqGM: OBIO) has been added to the Russell 2000 Index. This inclusion is a significant development for the biomedical innovation company, which specializes in therapies for hypertension and atherosclerotic artery disease. The article also provi", "url": "https://www.marketscreener.com/news/orchestra-biomed-holdings-inc-nasdaqgm-obio-added-to-russell-2000-index-ce7f5fdfdc8ff424", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T17:48:00", "published_display": "29 Jun 2026 17:48", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed joins Russell 2000 and 3000 indexes", "summary": "Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has been added to the Russell 3000 and Russell 2000 indexes as part of the 2026 annual reconstitution. This inclusion, effective after the U.S. market close on Friday, means the company, with a $254 million market capitalization and 5", "url": "https://m.uk.investing.com/news/stock-market-news/orchestra-biomed-joins-russell-2000-and-3000-indexes-93CH-4748351?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-29T12:13:41", "published_display": "29 Jun 2026 12:13", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed lands in Russell indexes tracking $12.2T", "summary": "Orchestra BioMed (NASDAQ: OBIO) has announced its inclusion in the broad-market Russell 3000\u00ae Index and the small-cap Russell 2000\u00ae Index, effective June 26, 2026, after the U.S. market close. This membership provides automatic inclusion in related growth and value indexes, as Ru", "url": "https://www.stocktitan.net/news/OBIO/orchestra-bio-med-joins-russell-3000-and-russell-2000-jv6tpo0fqti1.html", "source_name": "Stock Titan", "published_at": "2026-06-29T12:13:40", "published_display": "29 Jun 2026 12:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Joins Russell 3000\u00ae and Russell 2000\u00ae Indexes", "summary": "Orchestra BioMed Holdings, Inc. announced its inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index, effective June 26, 2026, following the annual reconstitution of Russell indexes. This membership means automatic inclusion in various growth and value style indexes, signal", "url": "https://sg.finance.yahoo.com/news/orchestra-biomed-joins-russell-3000-120000252.html", "source_name": "Market source", "published_at": "2026-06-29T12:13:40", "published_display": "29 Jun 2026 12:13", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2000 Growth Benchmark", "summary": "Orchestra BioMed Holdings, Inc. (NasdaqGM:OBIO) has been added to the Russell 2000 Growth Benchmark. The company specializes in biomedical innovation with lead product candidates including Atrioventricular Interval Modulation (AVIM) therapy for hypertension and Virtue Sirolimus A", "url": "https://www.marketscreener.com/news/orchestra-biomed-holdings-inc-nasdaqgm-obio-added-to-russell-2000-growth-benchmark-ce7f5fded18af224", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:13:40", "published_display": "29 Jun 2026 11:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed stock rises after Russell index addition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQlBEZDRvT2xPb1E2WHBHZnFyQWg2TjVuMnF5ZW9CaUVYVlBjemM5YjJMeVBQTkVnS3oyaFJTYnVxbnFpMlR4SUZ6V3ZiRzNIeVFfRkgyMmVEWWtjWG1Ocm5lcW05b3ZETU9Cb2JPaWxFQkJYUXdKclAwVUIzbnFfc0hSMGJhYk1nY2ZiNnM3WDZiRVhKeG44ZVpvYWQ1RDBUbGlpbDc1TzlSajdwaFlEX1BPMTNYWVVEc2JF?oc=5", "source_name": "Investing.com", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc. Actuals & Estimates (NASDAQ:OBIO)", "summary": "This article provides financial actuals and estimates for Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), detailing its stock performance, analyst forecasts, earnings, revenue, and other key financial metrics. It includes frequently asked questions about OBIO's stock price, market", "url": "https://www.tradingview.com/symbols/NASDAQ-OBIO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T04:39:55", "published_display": "26 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OBIO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Orchestra BioMed Holdings, Inc. (OBIO) stock, including analyst price targets, historical performance, and financial data. Analysts have a maximum price target of $20.00 and a minimum of $9.00 for OBIO. The company's stock has shown recent gain", "url": "https://www.tradingview.com/symbols/NASDAQ-OBIO/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T01:40:39", "published_display": "26 Jun 2026 01:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Orchestra Biomed Holdings Inc For: 25 June By Investing.com", "summary": "This article provides a Form 4 filing for Orchestra Biomed Holdings Inc. for June 25, indicating potential insider trading activity. It lists the stock symbol OBIO and mentions a modest price increase for the company, alongside various market indices and commodity prices.", "url": "https://ng.investing.com/news/stock-market-news/form-4-orchestra-biomed-holdings-inc-for-25-june-93CH-2574856", "source_name": "Investing.com Nigeria", "published_at": "2026-06-26T00:39:55", "published_display": "26 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (NASDAQ: OBIO) director receives new RSU and stock option grants", "summary": "Orchestra BioMed Holdings, Inc. director Pamela Ann Connealy received 17,327 restricted stock units (RSUs) and stock options for 21,277 shares, as compensation. The RSUs and stock options were granted on June 23, 2026, with an exercise price of $4.0400 per share, and both will ve", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-51cbfa537b13.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director granted RSUs, shares withheld for taxes", "summary": "Orchestra BioMed Holdings, Inc. director John Prosper Mack received an award of 34,653 Restricted Stock Units (RSUs) on June 23, 2026, which will vest after one year of continuous service. Concurrently, 3,510 shares were withheld from previously vested RSUs to cover tax obligatio", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-72fc701fd1f9.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director logs RSU tax withholding and 42,553-option grant", "summary": "Orchestra BioMed Holdings director Chris Cleary reported compensation-related equity transactions, including the disposal of 3,510 common shares for tax obligations tied to restricted stock units (RSUs) vesting. He also received a grant of stock options for 42,553 shares at an ex", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-a58c7dac94bb.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director receives 42,553 stock options at $4.04 strike", "summary": "Orchestra BioMed Holdings director Aryeh Jason was granted 42,553 stock options at an exercise price of $4.04 per share. These options, which have no upfront cash payment, will vest on the one-year anniversary of the June 23, 2026 grant date, provided Jason continues his service ", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-fd361420727f.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld", "summary": "Orchestra BioMed Holdings director Eric S. Fain, through the Fain Living Trust, received grants of 17,327 restricted stock units (RSUs) and 21,277 stock options on June 23, 2026, with an exercise price of $4.04 per share, both vesting after one year of continuous service. On June", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-dac3fd177e19.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed shareholders approve director elections and key proposals at annual meeting", "summary": "Orchestra BioMed Holdings, Inc. shareholders approved all five proposals at their 2026 Annual Meeting, including the election of three Class III directors, the ratification of Ernst & Young LLP as their accounting firm, and the adoption of the 2026 Employee Stock Purchase Plan. S", "url": "https://www.investing.com/news/sec-filings/orchestra-biomed-shareholders-approve-director-elections-and-key-proposals-at-annual-meeting-93CH-4757117", "source_name": "Investing.com", "published_at": "2026-06-24T00:40:46", "published_display": "24 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com", "summary": "This article reports on the filing of a Form 8K by Orchestra Biomed Holdings Inc. for June 23, 2026. It notes that Orchestra Biomed Holdings Inc. (OBIO) saw an 8.72% increase. The article provides the title, author, and publication timestamp.", "url": "https://ng.investing.com/news/stock-market-news/form-8k-orchestra-biomed-holdings-inc-for-23-june-93CH-2570982", "source_name": "Investing.com Nigeria", "published_at": "2026-06-23T22:04:00", "published_display": "23 Jun 2026 22:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items", "summary": "Orchestra BioMed Holdings, Inc. announced the results of its 2026 Annual Meeting of Stockholders, where five proposals were acted upon. Shareholders elected three Class III directors, ratified Ernst & Young LLP as the independent auditor for 2026, and approved the 2026 equity inc", "url": "https://www.stocktitan.net/sec-filings/OBIO/8-k-orchestra-bio-med-holdings-inc-reports-material-event-1e6f3746a69e.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:39:11", "published_display": "23 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings (OBIO) Bounces from Support: +2.26% Gain Signals Potential Recovery - Mean Reversion Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQZUYzajRJWmdvaHF0XzZXRmxxaHg5bjhYS2Vyc0Zja2FXNkZQMDhtTlphZ1JIQnlpUkJqTjZfeGtZOU05NlVzdFZpUTlKMmRzX2VsZW1CUGdvdGhIZFFUWnpHV25hUFkwM0U5MjdEcktRejRublY0VDhCTC02UHdWNUZlNmpobUtNZThRTU0yT0xMQ0JRamNhbUFnZFZGR0hpT0FpRUZ1VDRQR0NqWmxHSnc3Z19wSTFsYXg0YmxpbDJMWUYwUUxaU0Mtd2pVaG8?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG", "summary": "BTIG analyst maintained a Hold rating on Orchestra BioMed Holdings (OBIO) on June 15, with the company's shares closing at $3.97. Despite a strong buy consensus with an average price target of $11.40, Orchestra BioMed reported a Q1 revenue of $110 thousand and a GAAP net loss of ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/OBIO-Q/pressreleases/2548477/orchestra-biomed-holdings-obio-gets-a-hold-from-btig/", "source_name": "The Globe and Mail", "published_at": "2026-06-19T23:10:21", "published_display": "19 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence", "summary": "Orchestra Biomed Holdings Inc (OBIO) currently has an institutional shareholding score of 3.00, placing it 132nd out of 204 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 42.19%, reflecting a 7.86% increase quarter-over-quarter. Stev", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-obio/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T09:39:01", "published_display": "18 Jun 2026 09:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Orchestra Biomed Holdings Inc (OBIO) has an earnings forecast score of 8.00, placing it 66th in its industry, with analysts setting an average price target of $12.00. The company's expected revenue for the next quarter is $121.40K, and the majority of analysts recommend a \"Buy\" r", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-obio/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T23:10:02", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra Biomed Holdings Inc (OBIO) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Orchestra Biomed Holdings Inc (OBIO) has a current financial score of 5.60, placing it 196 out of 204 in the Healthcare Equipment & Supplies industry. The company's financial status is stable, but operating efficiency is low, with its latest quarterly revenue decreasing by 87.33%", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-obio/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:02", "published_display": "17 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orchestra-biomed-announces-inducement-grants-200500911.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T20:05:00+00:00", "published_display": "02 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) Rebounds: Key Levels to Watch After 2% Gain - PCR Moving Average", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOR1o5LUFzVDRLWTUyZlhxZGIyd0c5WTlyTHVXdGVLa2dzMU9sRkpkMk5RSzFuZzdBb1BXVGNsUU1jZ1QweDA1TkF5VWJRM3o0NG16Uk9YbUpCR055ZDFxdWZPQXNRLWRISzc1Z1hReUs3Nl9MWE9LQzZUZUFfdnRoTUUxTm51UmF4UElZRllFVEM0S0hQeF82NFF3SV9mUVlCX2R0WXh1U1c?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings (OBIO) Slips Slightly as Stock Hovers Near Support - ETF AUM Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOQ3hwbG0xdDdyQWV2SUtCUXVYRzNXMzRUVnFhaVN0Z3ZyWk9yNWxmVU53OEU2aG5qMV9mbDMzaFVBZGpkSzMzWnB5ZzZTdFNyUWpZOGxMTk5sMzhjcWtoRHQ5VUdaanotbG4tQU50bThWM3hpOVJ4M1RKVmVaNGJJS2pJWGdXRW1IVHB2M0R6R2k5Z2lLcGdSRnJVT2Y5YmhYeVdwV1ExdWlsQ3lCYUEzZVp5U1JGY1dBLW9iMmx3?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/favourable-signals-orchestra-biomed-holdings-111059171.html", "source_name": "Simply Wall St.", "published_at": "2026-05-21T11:10:59+00:00", "published_display": "21 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orchestra-biomed-participate-jefferies-global-123000074.html", "source_name": "GlobeNewswire", "published_at": "2026-05-19T12:30:00+00:00", "published_display": "19 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/b-riley-cuts-price-target-114207341.html", "source_name": "MT Newswires", "published_at": "2026-05-19T11:42:07+00:00", "published_display": "19 May 2026 11:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/news/orchestra-biomed-holdings-inc-obio-214005335.html", "source_name": "Zacks", "published_at": "2026-05-12T21:40:05+00:00", "published_display": "12 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Q1 Loss Narrows, Revenue Falls", "summary": "", "url": "https://finance.yahoo.com/news/orchestra-biomed-q1-loss-narrows-205558612.html", "source_name": "MT Newswires", "published_at": "2026-05-12T20:55:58+00:00", "published_display": "12 May 2026 20:55", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates", "summary": "", "url": "https://finance.yahoo.com/news/orchestra-biomed-reports-first-quarter-201800590.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:18:00+00:00", "published_display": "12 May 2026 20:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orchestra-biomed-targeting-backbeat-trial-123000195.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:30:00+00:00", "published_display": "12 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNS1Z5SjIxRF9DNzJBVVFqMVd3MmtsbWN4VWlxam5pbC1kZmcwNDJ0ZFRwV0xhdmdaRUFvY2c5dlRpVERqdk8zY2trSkp3TDFoaEpzUjhxRkFuZHdsbzdIVFV4MVVCUk5rNG45bl9hWE5KbTdZejNkRVVTNlZDTlozWmNKekpCdVU?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRjRWTlZxLWcwa042d08tTUgxY3FwWVlVd21BcjhuMkROWTdUb3hTQk1NRFZzNVpRRnhOUUNZc045NmgwNkdrVjNfVWJsbmJ6ZUlfMVlZWVJIaDhJSDNQQm1MbUl1OVZZTGdac1dRSGVkOGpWUDdvYUNnWFJaTlN4NFdnVDhDUGRLOGJZdkVPVEVFaUFqZnR5S2RCekhJNlJXZE8wRVhZWWxlNU9LRVdMM3RmY2l1Nlh0NnJyMGZOb3BpZDhYZWc3aFdlX3l5azNrMm9aeFY3cjRqckgtOWN1SVRXWms?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed secures $111M in funding deals to advance heart care technologies", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPMW5vSGpnM0lEMFdNVmtiN0dJcHM1Y3lUQVhXeEVVWWs1UEJJRUZ6SFhnSE5BaU5xalhqRlBRVHUzRVNlLVFZR01CdHhHaDJhWjlteWY2TEFfTzJkd1JUU3hGOVFHa3phbHIwM0txNS00YVF0eE5pd09pNGUtSEp5cGZFTzFLb2hFWVN0QkNPQ05Qc2JHZDM5T2xhWFIyU01NbXVpN0NqZ1gwTDVDM3BF?oc=5", "source_name": "The Business Journals", "published_at": "2025-08-05T07:00:00+00:00", "published_display": "05 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5hbm45blYxeEdyZW85eHVmNHhSWmVVWUE0aEtjNXpuODdvd2lTUE1NUlIxSHhxY0RQZWVXX0NrMDZIUFpTb2ZzeXlYdjN2b1NodkdKeEM3Z1dDZw?oc=5", "source_name": "MarketBeat", "published_at": "2023-02-02T13:46:15+00:00", "published_display": "02 Feb 2023 13:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygJBVV95cUxNendwcERVWkJrRXFFV01DenNzYlNidlpHcjc2ZS1jR290Q2R4SGJXVWJLbHgzV3oySlJVZFVaRGlxeTFIcWRTUTRycVhLbjZrVW02S3JjdmI4ZnJCZ0YyYTVaTnNla1hRM2lOR0FoWkZhblRrNVVCaE1qMk5iUllBalRwVEJ5dEdBakFQRm82V1lxTHBaMk1ta3hSNGxQbWtGX2JhS3dzVVhvQmpNLXZmbU1ZUXpTd3Y0MjBteGNvSGEyNHAxLXl6VzdrS0YwRk51cklTVFA4OHZIendtOGpwNGo1NnRvcXU3X20xSDktUExoREM1TWJidHhIeEthbjh0T0h6TVBfUlFEZXJYRFFlR0NfbHNMVllkRDItN0Q5LWI3SXBIZGdBTmRyZlhVRnJHZHdra3NQYmFXcWpVdnNUSzRNNFdzbTQ0Smc?oc=5", "source_name": "GlobeNewswire", "published_at": "2023-01-27T08:00:00+00:00", "published_display": "27 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to earnings forward of Orchestra BioMed Holdings, Inc. \u2013 BOATS:OBIO", "summary": "This article provides financial information for Orchestra BioMed Holdings, Inc. (OBIO), specifically focusing on its \"Price to earnings forward\" metric. The content indicates that the market was closed with no trades recorded at the time of the data.", "url": "https://www.tradingview.com/symbols/BOATS-OBIO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T19:41:06", "published_display": "11 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OBIO - Orchestra BioMed Holdings Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings and comprehensive financial data for Orchestra BioMed Holdings Inc. (OBIO). It details the company's stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations, offering a snapshot of its", "url": "https://finviz.com/stock?t=OBIO&b=2&p=w&ty=lf&page=3", "source_name": "Finviz", "published_at": "2026-07-06T06:11:57", "published_display": "06 Jul 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Share Price, OBIO Stock News, OBIO Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE4tdU8wTmo0ODBneTJHRnFSbUc5ZC05SEx3Szl6Q0ZBdHBoNFl4NjZuMkZsZFZpU2lqcC12VEVnRG5TTUVKdldYNldsMllZTmtwNnZDSDNn?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T05:50:02+00:00", "published_display": "03 Jul 2026 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Darren Sherman Sells 15,000 Shares of Orchestra Bi", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPa0c0d2JWX0NrcjZZRWl2SFAtNDZvNXl5SXUwSXhvZ3NyMFExT1FKUTkzY2ZpYTlxdXhyU2hPLVJ2UnlMN2Y3V0NDRkRVd3puZ2EzMVE2UjNEN2lTQWVHRVpYaTBRVW90c3g4WnMzRWdsa1BpNXctQmEyV1prSFgwQ1NqcmM5TWtiT1g3RGxfX3J0ZzlqbWpDXzdMNVpuZjU4REJMaE1zSDRqY2VmN1BXNFJRZUp3ZDR4MGQ3alhIUjU?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-02T22:44:36+00:00", "published_display": "02 Jul 2026 22:44", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan", "summary": "Darren Sherman, a director and officer of Orchestra BioMed Holdings (OBIO), sold 15,000 shares of common stock at a weighted average price of $4.27 per share. This transaction, executed under a pre-established Rule 10b5-1 trading plan adopted on December 18, 2025, involved sales ", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-5b4299d483a1.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:01", "published_display": "02 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO)", "summary": "Darren Sherman has filed a Form 144 indicating an intent to sell 15,000 shares of Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) common stock, with a proposed sale date of June 1, 2026, and a reported gross amount of $58,049.53. The filing also details prior restricted stock vest", "url": "https://www.stocktitan.net/sec-filings/OBIO/144-orchestra-bio-med-holdings-inc-sec-filing-c8a8815dc3ce.html", "source_name": "Stock Titan", "published_at": "2026-07-01T15:45:05", "published_display": "01 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings' Market Cap Up US$40m Following Year Of Insider Stock Buying", "summary": "Orchestra BioMed Holdings (NASDAQ:OBIO) saw its market capitalization increase by US$40 million after a 16% stock rise, rewarding insiders who bought shares over the past year with a 36% gain. Insiders purchased US$321.7k worth of stock, now valued at US$438.9k, with the biggest ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-obio/orchestra-biomed-holdings/news/orchestra-biomed-holdings-market-cap-up-us40m-following-year", "source_name": "Simply Wall Street", "published_at": "2026-06-30T11:39:50", "published_display": "30 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes", "summary": "Orchestra BioMed Holdings, Inc. has been added to the Russell 3000 and Russell 2000 Indexes, effective July 1, 2026, as part of the annual reconstitution. This inclusion is expected to increase the company's visibility within the investment community. The Russell indexes are wide", "url": "https://www.moomoo.com/news/post/72190309/orchestra-biomed-joins-russell-3000-and-russell-2000-indexes", "source_name": "Moomoo", "published_at": "2026-06-30T05:09:33", "published_display": "30 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2500 Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPNWZyTGhoYWtwc3FleG83SGRyVmpiT0ZZOFlrOXYzX3NIajE2RFY0NzNSR01mZS1aT3pBMVZNakk3aE5pX2hicFhMNTVpaDZVNlZNQ3IwaUJYMHhIUWRfMWROMWdjTTRSNXFVSWsxaXdla3FKa2N6aUdCdlJFajA5RGZhQ3lZM3ZSaENQY2NpRElhSV8zMFZ6dDlhRlo5VUZwQjlYOTIyZE1OQnp4bmNOOWF6V2ZoYWxZRUhFUDFENTVZYUFSbklIdF8yTUkxQzYt?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-29T19:59:08+00:00", "published_display": "29 Jun 2026 19:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Index", "summary": "Orchestra BioMed Holdings, Inc. (NasdaqGM: OBIO) has been added to the Russell 2000 Index. This inclusion is a significant development for the biomedical innovation company, which specializes in therapies for hypertension and atherosclerotic artery disease. The article also provi", "url": "https://www.marketscreener.com/news/orchestra-biomed-holdings-inc-nasdaqgm-obio-added-to-russell-2000-index-ce7f5fdfdc8ff424", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T17:48:00", "published_display": "29 Jun 2026 17:48", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed joins Russell 2000 and 3000 indexes", "summary": "Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has been added to the Russell 3000 and Russell 2000 indexes as part of the 2026 annual reconstitution. This inclusion, effective after the U.S. market close on Friday, means the company, with a $254 million market capitalization and 5", "url": "https://m.uk.investing.com/news/stock-market-news/orchestra-biomed-joins-russell-2000-and-3000-indexes-93CH-4748351?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-29T12:13:41", "published_display": "29 Jun 2026 12:13", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed lands in Russell indexes tracking $12.2T", "summary": "Orchestra BioMed (NASDAQ: OBIO) has announced its inclusion in the broad-market Russell 3000\u00ae Index and the small-cap Russell 2000\u00ae Index, effective June 26, 2026, after the U.S. market close. This membership provides automatic inclusion in related growth and value indexes, as Ru", "url": "https://www.stocktitan.net/news/OBIO/orchestra-bio-med-joins-russell-3000-and-russell-2000-jv6tpo0fqti1.html", "source_name": "Stock Titan", "published_at": "2026-06-29T12:13:40", "published_display": "29 Jun 2026 12:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Joins Russell 3000\u00ae and Russell 2000\u00ae Indexes", "summary": "Orchestra BioMed Holdings, Inc. announced its inclusion in the Russell 3000\u00ae Index and Russell 2000\u00ae Index, effective June 26, 2026, following the annual reconstitution of Russell indexes. This membership means automatic inclusion in various growth and value style indexes, signal", "url": "https://sg.finance.yahoo.com/news/orchestra-biomed-joins-russell-3000-120000252.html", "source_name": "Market source", "published_at": "2026-06-29T12:13:40", "published_display": "29 Jun 2026 12:13", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2000 Growth Benchmark", "summary": "Orchestra BioMed Holdings, Inc. (NasdaqGM:OBIO) has been added to the Russell 2000 Growth Benchmark. The company specializes in biomedical innovation with lead product candidates including Atrioventricular Interval Modulation (AVIM) therapy for hypertension and Virtue Sirolimus A", "url": "https://www.marketscreener.com/news/orchestra-biomed-holdings-inc-nasdaqgm-obio-added-to-russell-2000-growth-benchmark-ce7f5fded18af224", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T11:13:40", "published_display": "29 Jun 2026 11:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed stock rises after Russell index addition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQlBEZDRvT2xPb1E2WHBHZnFyQWg2TjVuMnF5ZW9CaUVYVlBjemM5YjJMeVBQTkVnS3oyaFJTYnVxbnFpMlR4SUZ6V3ZiRzNIeVFfRkgyMmVEWWtjWG1Ocm5lcW05b3ZETU9Cb2JPaWxFQkJYUXdKclAwVUIzbnFfc0hSMGJhYk1nY2ZiNnM3WDZiRVhKeG44ZVpvYWQ1RDBUbGlpbDc1TzlSajdwaFlEX1BPMTNYWVVEc2JF?oc=5", "source_name": "Investing.com", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc. Actuals & Estimates (NASDAQ:OBIO)", "summary": "This article provides financial actuals and estimates for Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), detailing its stock performance, analyst forecasts, earnings, revenue, and other key financial metrics. It includes frequently asked questions about OBIO's stock price, market", "url": "https://www.tradingview.com/symbols/NASDAQ-OBIO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T04:39:55", "published_display": "26 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OBIO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Orchestra BioMed Holdings, Inc. (OBIO) stock, including analyst price targets, historical performance, and financial data. Analysts have a maximum price target of $20.00 and a minimum of $9.00 for OBIO. The company's stock has shown recent gain", "url": "https://www.tradingview.com/symbols/NASDAQ-OBIO/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T01:40:39", "published_display": "26 Jun 2026 01:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Orchestra Biomed Holdings Inc For: 25 June By Investing.com", "summary": "This article provides a Form 4 filing for Orchestra Biomed Holdings Inc. for June 25, indicating potential insider trading activity. It lists the stock symbol OBIO and mentions a modest price increase for the company, alongside various market indices and commodity prices.", "url": "https://ng.investing.com/news/stock-market-news/form-4-orchestra-biomed-holdings-inc-for-25-june-93CH-2574856", "source_name": "Investing.com Nigeria", "published_at": "2026-06-26T00:39:55", "published_display": "26 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (NASDAQ: OBIO) director receives new RSU and stock option grants", "summary": "Orchestra BioMed Holdings, Inc. director Pamela Ann Connealy received 17,327 restricted stock units (RSUs) and stock options for 21,277 shares, as compensation. The RSUs and stock options were granted on June 23, 2026, with an exercise price of $4.0400 per share, and both will ve", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-51cbfa537b13.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director granted RSUs, shares withheld for taxes", "summary": "Orchestra BioMed Holdings, Inc. director John Prosper Mack received an award of 34,653 Restricted Stock Units (RSUs) on June 23, 2026, which will vest after one year of continuous service. Concurrently, 3,510 shares were withheld from previously vested RSUs to cover tax obligatio", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-72fc701fd1f9.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director logs RSU tax withholding and 42,553-option grant", "summary": "Orchestra BioMed Holdings director Chris Cleary reported compensation-related equity transactions, including the disposal of 3,510 common shares for tax obligations tied to restricted stock units (RSUs) vesting. He also received a grant of stock options for 42,553 shares at an ex", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-a58c7dac94bb.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director receives 42,553 stock options at $4.04 strike", "summary": "Orchestra BioMed Holdings director Aryeh Jason was granted 42,553 stock options at an exercise price of $4.04 per share. These options, which have no upfront cash payment, will vest on the one-year anniversary of the June 23, 2026 grant date, provided Jason continues his service ", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-fd361420727f.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld", "summary": "Orchestra BioMed Holdings director Eric S. Fain, through the Fain Living Trust, received grants of 17,327 restricted stock units (RSUs) and 21,277 stock options on June 23, 2026, with an exercise price of $4.04 per share, both vesting after one year of continuous service. On June", "url": "https://www.stocktitan.net/sec-filings/OBIO/form-4-orchestra-bio-med-holdings-inc-insider-trading-activity-dac3fd177e19.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:11:41", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed shareholders approve director elections and key proposals at annual meeting", "summary": "Orchestra BioMed Holdings, Inc. shareholders approved all five proposals at their 2026 Annual Meeting, including the election of three Class III directors, the ratification of Ernst & Young LLP as their accounting firm, and the adoption of the 2026 Employee Stock Purchase Plan. S", "url": "https://www.investing.com/news/sec-filings/orchestra-biomed-shareholders-approve-director-elections-and-key-proposals-at-annual-meeting-93CH-4757117", "source_name": "Investing.com", "published_at": "2026-06-24T00:40:46", "published_display": "24 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com", "summary": "This article reports on the filing of a Form 8K by Orchestra Biomed Holdings Inc. for June 23, 2026. It notes that Orchestra Biomed Holdings Inc. (OBIO) saw an 8.72% increase. The article provides the title, author, and publication timestamp.", "url": "https://ng.investing.com/news/stock-market-news/form-8k-orchestra-biomed-holdings-inc-for-23-june-93CH-2570982", "source_name": "Investing.com Nigeria", "published_at": "2026-06-23T22:04:00", "published_display": "23 Jun 2026 22:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items", "summary": "Orchestra BioMed Holdings, Inc. announced the results of its 2026 Annual Meeting of Stockholders, where five proposals were acted upon. Shareholders elected three Class III directors, ratified Ernst & Young LLP as the independent auditor for 2026, and approved the 2026 equity inc", "url": "https://www.stocktitan.net/sec-filings/OBIO/8-k-orchestra-bio-med-holdings-inc-reports-material-event-1e6f3746a69e.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:39:11", "published_display": "23 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings (OBIO) Bounces from Support: +2.26% Gain Signals Potential Recovery - Mean Reversion Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQZUYzajRJWmdvaHF0XzZXRmxxaHg5bjhYS2Vyc0Zja2FXNkZQMDhtTlphZ1JIQnlpUkJqTjZfeGtZOU05NlVzdFZpUTlKMmRzX2VsZW1CUGdvdGhIZFFUWnpHV25hUFkwM0U5MjdEcktRejRublY0VDhCTC02UHdWNUZlNmpobUtNZThRTU0yT0xMQ0JRamNhbUFnZFZGR0hpT0FpRUZ1VDRQR0NqWmxHSnc3Z19wSTFsYXg0YmxpbDJMWUYwUUxaU0Mtd2pVaG8?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG", "summary": "BTIG analyst maintained a Hold rating on Orchestra BioMed Holdings (OBIO) on June 15, with the company's shares closing at $3.97. Despite a strong buy consensus with an average price target of $11.40, Orchestra BioMed reported a Q1 revenue of $110 thousand and a GAAP net loss of ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/OBIO-Q/pressreleases/2548477/orchestra-biomed-holdings-obio-gets-a-hold-from-btig/", "source_name": "The Globe and Mail", "published_at": "2026-06-19T23:10:21", "published_display": "19 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence", "summary": "Orchestra Biomed Holdings Inc (OBIO) currently has an institutional shareholding score of 3.00, placing it 132nd out of 204 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 42.19%, reflecting a 7.86% increase quarter-over-quarter. Stev", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-obio/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T09:39:01", "published_display": "18 Jun 2026 09:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Orchestra Biomed Holdings Inc (OBIO) has an earnings forecast score of 8.00, placing it 66th in its industry, with analysts setting an average price target of $12.00. The company's expected revenue for the next quarter is $121.40K, and the majority of analysts recommend a \"Buy\" r", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-obio/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T23:10:02", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra Biomed Holdings Inc (OBIO) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Orchestra Biomed Holdings Inc (OBIO) has a current financial score of 5.60, placing it 196 out of 204 in the Healthcare Equipment & Supplies industry. The company's financial status is stable, but operating efficiency is low, with its latest quarterly revenue decreasing by 87.33%", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-obio/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:02", "published_display": "17 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orchestra-biomed-announces-inducement-grants-200500911.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T20:05:00+00:00", "published_display": "02 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) Rebounds: Key Levels to Watch After 2% Gain - PCR Moving Average", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOR1o5LUFzVDRLWTUyZlhxZGIyd0c5WTlyTHVXdGVLa2dzMU9sRkpkMk5RSzFuZzdBb1BXVGNsUU1jZ1QweDA1TkF5VWJRM3o0NG16Uk9YbUpCR055ZDFxdWZPQXNRLWRISzc1Z1hReUs3Nl9MWE9LQzZUZUFfdnRoTUUxTm51UmF4UElZRllFVEM0S0hQeF82NFF3SV9mUVlCX2R0WXh1U1c?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings (OBIO) Slips Slightly as Stock Hovers Near Support - ETF AUM Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOQ3hwbG0xdDdyQWV2SUtCUXVYRzNXMzRUVnFhaVN0Z3ZyWk9yNWxmVU53OEU2aG5qMV9mbDMzaFVBZGpkSzMzWnB5ZzZTdFNyUWpZOGxMTk5sMzhjcWtoRHQ5VUdaanotbG4tQU50bThWM3hpOVJ4M1RKVmVaNGJJS2pJWGdXRW1IVHB2M0R6R2k5Z2lLcGdSRnJVT2Y5YmhYeVdwV1ExdWlsQ3lCYUEzZVp5U1JGY1dBLW9iMmx3?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/favourable-signals-orchestra-biomed-holdings-111059171.html", "source_name": "Simply Wall St.", "published_at": "2026-05-21T11:10:59+00:00", "published_display": "21 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orchestra-biomed-participate-jefferies-global-123000074.html", "source_name": "GlobeNewswire", "published_at": "2026-05-19T12:30:00+00:00", "published_display": "19 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/b-riley-cuts-price-target-114207341.html", "source_name": "MT Newswires", "published_at": "2026-05-19T11:42:07+00:00", "published_display": "19 May 2026 11:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/news/orchestra-biomed-holdings-inc-obio-214005335.html", "source_name": "Zacks", "published_at": "2026-05-12T21:40:05+00:00", "published_display": "12 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Q1 Loss Narrows, Revenue Falls", "summary": "", "url": "https://finance.yahoo.com/news/orchestra-biomed-q1-loss-narrows-205558612.html", "source_name": "MT Newswires", "published_at": "2026-05-12T20:55:58+00:00", "published_display": "12 May 2026 20:55", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates", "summary": "", "url": "https://finance.yahoo.com/news/orchestra-biomed-reports-first-quarter-201800590.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:18:00+00:00", "published_display": "12 May 2026 20:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orchestra-biomed-targeting-backbeat-trial-123000195.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:30:00+00:00", "published_display": "12 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNS1Z5SjIxRF9DNzJBVVFqMVd3MmtsbWN4VWlxam5pbC1kZmcwNDJ0ZFRwV0xhdmdaRUFvY2c5dlRpVERqdk8zY2trSkp3TDFoaEpzUjhxRkFuZHdsbzdIVFV4MVVCUk5rNG45bl9hWE5KbTdZejNkRVVTNlZDTlozWmNKekpCdVU?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRjRWTlZxLWcwa042d08tTUgxY3FwWVlVd21BcjhuMkROWTdUb3hTQk1NRFZzNVpRRnhOUUNZc045NmgwNkdrVjNfVWJsbmJ6ZUlfMVlZWVJIaDhJSDNQQm1MbUl1OVZZTGdac1dRSGVkOGpWUDdvYUNnWFJaTlN4NFdnVDhDUGRLOGJZdkVPVEVFaUFqZnR5S2RCekhJNlJXZE8wRVhZWWxlNU9LRVdMM3RmY2l1Nlh0NnJyMGZOb3BpZDhYZWc3aFdlX3l5azNrMm9aeFY3cjRqckgtOWN1SVRXWms?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed secures $111M in funding deals to advance heart care technologies", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPMW5vSGpnM0lEMFdNVmtiN0dJcHM1Y3lUQVhXeEVVWWs1UEJJRUZ6SFhnSE5BaU5xalhqRlBRVHUzRVNlLVFZR01CdHhHaDJhWjlteWY2TEFfTzJkd1JUU3hGOVFHa3phbHIwM0txNS00YVF0eE5pd09pNGUtSEp5cGZFTzFLb2hFWVN0QkNPQ05Qc2JHZDM5T2xhWFIyU01NbXVpN0NqZ1gwTDVDM3BF?oc=5", "source_name": "The Business Journals", "published_at": "2025-08-05T07:00:00+00:00", "published_display": "05 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed (OBIO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5hbm45blYxeEdyZW85eHVmNHhSWmVVWUE0aEtjNXpuODdvd2lTUE1NUlIxSHhxY0RQZWVXX0NrMDZIUFpTb2ZzeXlYdjN2b1NodkdKeEM3Z1dDZw?oc=5", "source_name": "MarketBeat", "published_at": "2023-02-02T13:46:15+00:00", "published_display": "02 Feb 2023 13:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygJBVV95cUxNendwcERVWkJrRXFFV01DenNzYlNidlpHcjc2ZS1jR290Q2R4SGJXVWJLbHgzV3oySlJVZFVaRGlxeTFIcWRTUTRycVhLbjZrVW02S3JjdmI4ZnJCZ0YyYTVaTnNla1hRM2lOR0FoWkZhblRrNVVCaE1qMk5iUllBalRwVEJ5dEdBakFQRm82V1lxTHBaMk1ta3hSNGxQbWtGX2JhS3dzVVhvQmpNLXZmbU1ZUXpTd3Y0MjBteGNvSGEyNHAxLXl6VzdrS0YwRk51cklTVFA4OHZIendtOGpwNGo1NnRvcXU3X20xSDktUExoREM1TWJidHhIeEthbjh0T0h6TVBfUlFEZXJYRFFlR0NfbHNMVllkRDItN0Q5LWI3SXBIZGdBTmRyZlhVRnJHZHdra3NQYmFXcWpVdnNUSzRNNFdzbTQ0Smc?oc=5", "source_name": "GlobeNewswire", "published_at": "2023-01-27T08:00:00+00:00", "published_display": "27 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 90, "total_relevant": 54, "sentiment_summary": {"positive": 15, "negative": 6, "neutral": 33, "score": 54, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 17.05, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 8.6, "count": 17}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 3.99, "latest_week": "2026-07-10", "one_week_move": -4.8, "four_week_move": -2.7, "twelve_week_move": -12.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.412759, "market_dynamics_buy_signal": false, "relative_strength": -9.551704, "fair_value_gap": -20.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.9518, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.8% over one week, -2.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 9}, {"label": "Market source", "count": 7}, {"label": "GlobeNewswire", "count": 6}, {"label": "TradingView", "count": 4}, {"label": "Investing.com", "count": 3}, {"label": "TradingKey", "count": 3}, {"label": "www.marketscreener.com", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 46}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 17}, {"label": "Analyst action", "count": 4}, {"label": "Macro sensitivity", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "46", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.8% over one week, -2.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to earnings forward of Orchestra BioMed Holdings, Inc. \u2013 BOATS:OBIO"}], "updated_at": "2026-07-16T11:51:12.266110+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}